Results 61 to 70 of about 18,913,418 (345)
Investigation protocol: Acromegaly and its investigation [PDF]
The diagnosis of acromegalyAcromegaly is an uncommon but serious disease due to anexcessive production of growth hormone (GH), usually from apituitary tumour. Although it has an insidious onset, onceclinically suspected its diagnosis is not usually difficult.
Duncan E., Wass J.A.H.
openaire +6 more sources
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben +4 more
wiley +1 more source
Mogamulizumab, a humanized defucosylated anti-C-C chemokine receptor 4 monoclonal antibody, has been approved in Japan for the treatment of C-C chemokine receptor 4-positive adult T-cell leukemia/lymphoma (ATL). This phase II study evaluated efficacy and
A. Phillips +18 more
semanticscholar +1 more source
Herpes zoster (HZ) mainly affects older adults and immunocompromised individuals and is usually characterized by a unilateral painful skin rash. Its most common complication, postherpetic neuralgia (PHN), may cause chronic debilitating pain lasting for ...
Andrea Salvetti +14 more
doaj +1 more source
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk +10 more
wiley +1 more source
Preclinical efficacy studies in investigator brochures: Do they enable risk–benefit assessment?
Human protection policies require favorable risk–benefit judgments prior to launch of clinical trials. For phase I and II trials, evidence for such judgment often stems from preclinical efficacy studies (PCESs). We undertook a systematic investigation of
S. Wieschowski +5 more
semanticscholar +1 more source
<p>Although a minor release, Code Base Investigator v1.2.0 includes a few significant changes.</p> <blockquote> <p><strong>IMPORTANT</strong><br>In previous releases of Code Base Investigator, the main script was
Douglas Jacobsen +2 more
core +1 more source
[Title supplied by cataloger]Young Investigator Adrian Salic at Experimental Biology ...
Unknown
core +4 more sources
The subject. The article is devoted to the investigation of the main direct object and the circle of victims are subjected of harm by criminal acts stipulated by pts. 1, 2 of art.
A. V. Boyarskaya
doaj +1 more source
Clinical trial insurance in Serbia [PDF]
Prior the commencement of the clinical trial in Serbia the Sponsor is obliged to provide the insurance policy covering the patient's bodily injury and damaged health caused by the clinical trial. According to provisions of Serbian Insurance law insurance
Žagar Zlatko A.
doaj +1 more source

